Loading…
20,252 grants found
Showing 1,601 – 1,620 of 20,252 grants
PROJECT ABSTRACT: Hepatocellular carcinoma (HCC) is an aggressive malignancy representing the 7th most common cancer globally and the 4th most common cause of cancer death worldwid...
ABSTRACT Approximately 120,000 Americans with neurofibromatosis type I (NF1) suffer a constellation of clinical manifestations, including aberrant proliferation of neural tissues l...
Project Summary/Abstract This is a proposal to fund an established post-doctoral training program called the Columbia Cancer Research Training Program for Resident-Investigators (C...
PROJECT SUMMARY/ABSTRACT: Sepsis is a life-threatening medical condition characterized by high levels of inflammatory markers and multi-organ damage. Despite standard treatment, se...
Project Summary Although cancer immunotherapy has been proclaimed a breakthrough in many types of cancer, pancreatic ductal adenocarcinoma (PDAC) responds poorly to immune checkpoi...
ABSTRACT Metastasis contributes to the vast majority of breast cancer deaths but current therapies for disseminated disease have limited efficacy and significant side effects. Immu...
Project Summary: Adoptive cellular immunotherapy utilizing T cells engineered with chimeric antigen receptor (CAR) has shown durable clinical responses in hematologic malignancies....
PROGRAM SUMMARY Recent epidemiologic evidence highlights the significant unmet behavioral health needs of cancer patients in the United States. A strong evidence base now supports...
PROJECT SUMMARY/ABSTRACT Mutations in the human genome give rise to many human diseases including cancer. Mutations are also beneficial for processes including evolution and adapti...
Abstract Digital assays — in which ultra-sensitive molecular measurements are made by performing millions of parallel experiments in picoliter droplets — have generated much recent...
SUMMARY. The DNA Damage, Mutation and Cancer Gordon Research Conference (GRC) is a leading international scientific conference focused on advancing science through the presentation...
The clinical experience with anti-PD-1 immune checkpoint inhibition in ovarian cancer has been disappointing. The poor outcomes may at least in part be due to the highly immunosupp...
Project Summary Chromatin context defines all DNA transactions, from gene regulation to genome maintenance. Changes in chromatin composition are hallmarks of cancer cells that cont...
Pancreatic ductal adenocarincomas (PDAC) is an aggressive disease with poor prognosis and is characterized by a unique microenvironment that is severely depleted of amino acids (AA...
ABSTRACT We are pursuing the first anti-tumor small molecules that act specifically against human Sonic Hh protein autoprocessing, a unique biosynthetic event that is necessary to...
Abstract Immune checkpoint inhibition (ICI) can control intracranial disease in approximately 50% of patients with melanoma brain metastases (MBM), which is the leading cause of de...
PROJECT SUMMARY The treatment of pancreatic ductal adenocarcinoma (PDAC) remains a major hurdle with 5-year survival of 12%. PDAC resistance to chemotherapy and immunotherapy is th...
Pancreatic ductal adenocarincomas (PDAC) is an aggressive disease with poor prognosis and is characterized by a unique microenvironment that is severely depleted of amino acids (AA...
Abstract To survive in the nutrient- and oxygen-deprived niche, cancer cells undergo a drastic metabolic reprogramming where they upregulate their endogenous lipid synthesis and ex...
SUMMARY We previously reported that the viability of some breast cancers depends on histone deacetylase 6 (HDAC6). We also developed a biomarker (HDAC6-score, validated with a NY C...